Investment Firm
Overview
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.
Jun 14, 2010
Series Unknown
Highlights
Location
Social
N/A
Investor Lead
N/A
Participant Investors
1
Investor Name |
---|
Asset Management Company |
InteKrin raised $2292809 on 2010-06-14 in Venture Round
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.
Company Funding History
8
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jan 12, 2007 | Series B - InteKrin | 6 | - | 23.0M |
Apr 02, 2009 | Venture Round - InteKrin | 1 | - | 21.4M |
Jun 14, 2010 | Venture Round - InteKrin | 1 | - | 2.3M |
Aug 04, 2008 | Series C - InteKrin | 8 | - | 18.5M |
Recent Activity
There is no recent news or activity for this profile.